CureApp, Inc.
CureApp, Inc.'s Overview
CureApp, Inc. is a pioneering Japanese medical technology company focused on developing and distributing 'Digital Therapeutics' (DTx). They create evidence-based, clinically validated software applications as medical devices to treat various diseases, aiming to provide novel therapeutic options. CureApp achieved a significant milestone by developing Japan's first regulatory-approved and reimbursed DTx app for nicotine addiction, followed by an app for hypertension. The company is committed to transforming healthcare by integrating advanced technology into medical practice, offering personalized, accessible, and effective treatment solutions for patients and healthcare providers. They are actively involved in research, development, and global expansion of their DTx portfolio.
Where is CureApp, Inc.'s Headquarters?
HQ Function
The global headquarters serves as the central hub for all corporate functions, including research and development of digital therapeutics, clinical trial management, product strategy, software engineering, business development, regulatory affairs, and administrative operations.
Notable Features:
Modern office facilities situated in a prominent business area, designed to foster collaboration and innovation. It is likely equipped with advanced IT infrastructure essential for software development and data-driven research in the digital health sector.
Work Culture:
CureApp promotes an innovative and agile work culture, blending Japanese precision and commitment to quality with the dynamism of a tech-driven healthcare company. There is a strong emphasis on scientific rigor, patient-centric solutions, and collaborative teamwork to pioneer new medical treatments.
HQ Significance:
The headquarters is pivotal to CureApp's leadership in the Japanese digital therapeutics market and its strategic initiatives for international expansion. It is the core site for developing and commercializing clinically validated DTx solutions that are at the forefront of medical innovation.
Values Reflected in HQ: The headquarters' environment and operations likely reflect CureApp's core values: 'Creating new treatment methods with software,' 'Patient-centricity,' 'Evidence-based medicine,' and 'Contributing to the future of medical care through technology.'
Location:
CureApp, Inc. is headquartered in Japan, where it has successfully launched prescription digital therapeutics and established a strong market presence. The company is actively pursuing global expansion, with a key strategic focus on the U.S. market through its subsidiary, CureApp North America, Inc. Their global functions encompass international business development, forming strategic partnerships with pharmaceutical companies and healthcare providers, conducting multi-regional clinical trials to meet diverse regulatory standards, and adapting their DTx solutions for new cultural and medical contexts. CureApp aims to make its innovative, evidence-based treatments accessible to patients worldwide, addressing unmet medical needs across different geographies.
Street Address:
Nihonbashi Honcho YS Building, 2-2-2 Nihonbashi Honcho
City:
Chuo-ku
State/Province:
Tokyo
Country:
Japan
CureApp, Inc.'s Global Presence
Dover, Delaware, USA
Address: 850 New Burton Rd Ste 201, Dover, DE 19904, USA
To establish and expand CureApp's presence in the North American digital therapeutics market. This includes facilitating partnerships, navigating FDA regulatory pathways, and preparing for the commercialization of its DTx products in the U.S. region.
Buying Intent Signals for CureApp, Inc.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of CureApp, Inc.
As of April 2025, CureApp, Inc.' leadership includes:
Investors of CureApp, Inc.
CureApp, Inc. has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
As of mid-2024, there have been no major C-suite executive hires or departures publicly announced by CureApp, Inc. in the immediately preceding 12 months. The core leadership team appears stable, continuing to focus on advancing the company's product pipeline, achieving commercial milestones, and pursuing its international expansion strategy, particularly in the U.S. market.
Technology (Tech Stack) used by CureApp, Inc.
Discover the tools CureApp, Inc. uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
CureApp, Inc. Email Formats and Examples
CureApp, Inc. likely utilizes standard corporate email formats common in technology and healthcare companies globally. While the exact primary format can vary internally, typical structures for professional communication often involve combinations of an employee's first name, last name, or initials, followed by the company domain '@cureapp.co.jp'. For general inquiries, the company provides a specific contact email or a form on their official website.
Common patterns include [first_initial][last]@cureapp.co.jp (e.g., jsmith@cureapp.co.jp) or [first].[last]@cureapp.co.jp (e.g., john.smith@cureapp.co.jp). The official company domain is cureapp.co.jp.
Format
ksatake@cureapp.co.jp (example based on CEO Kohta Satake's name and a common pattern; for official general contact, refer to their website, e.g., contact@cureapp.jp)
Example
85%
Success rate
News and media
CureApp, Inc. Press Release • May 14, 2024
CureApp, Inc. Announces Consolidated Financial Results for Fiscal Year Ended December 31, 2023
CureApp, Inc. released its consolidated financial results for the fiscal year ending December 31, 2023. The report highlighted revenue performance, primarily driven by sales and reimbursement of its digital therapeutics for nicotine addiction and hypertension in Japan. The company also outlined its continued investment in research and development for its expanding DTx pipeline and ongoing efforts towards global market expansion....more
CureApp, Inc. News Release • March 5, 2024
CureApp's CEO Kohta Satake to Speak at DTx West 2024
CureApp announced that its Co-founder and CEO, Kohta Satake, would be a featured speaker at the DTx West 2024 conference, a prominent event in the digital therapeutics industry. He was scheduled to participate in a fireside chat and a panel discussion, sharing insights on the evolving digital therapeutics market landscape, regulatory advancements, and CureApp's contributions and future strategic direction....more
CureApp, Inc. News Release • November 7, 2023
CureApp’s Abstract on Real-World Data of Prescription Digital Therapeutics for Nicotine Addiction Accepted for Presentation at the 2023 APSR Congress
CureApp announced that its research abstract detailing real-world evidence for its prescription digital therapeutic for nicotine addiction was accepted for presentation at the 27th Congress of the Asian Pacific Society of Respirology (APSR 2023). This highlights the company's commitment to generating and disseminating clinical evidence for its products....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including CureApp, Inc., are just a search away.